Impact of Fish Oil-enriched Lipid Emulsion on Fatty Acid and Inflammatory Response in Infants After Surgery
NCT ID: NCT04511299
Last Updated: 2020-08-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
12 participants
INTERVENTIONAL
2020-04-07
2020-07-13
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Inflammatory Responses to Lipid Emulsions in Children Before and After Open Heart Surgery
NCT00336908
Efficacy and Safety of a Fish Oil Containing Lipid Emulsion
NCT01176695
Influence of of a Lipid Emulsion on Inflammatory Response and Hepatic Function
NCT00600912
Different Lipid Emulsions in Acute Lung Injury Patients
NCT01814956
Effect of Docosahexaenoic Acid on the Inflammatory Response and Clinical Outcomes From Surgical Patients
NCT01049529
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Fish oil-enriched intravenous lipid emulsion
SMOFlipid 20%, given for 3 consecutive days with 1-4 g/kg/day.
SMOFlipid 20%
Fish oil-enriched intravenous lipid emulsion
Standard intavenous lipid emulsion
Lipofundin 20%, given for 3 consecutive days with 1-4 g/kg/day.
Lipofundin 20%
MCT/LCT standard intravenous lipid emulsion
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
SMOFlipid 20%
Fish oil-enriched intravenous lipid emulsion
Lipofundin 20%
MCT/LCT standard intravenous lipid emulsion
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* undergo gastrointestinal surgery
* get parenteral nutrition for at least 3 days
Exclusion Criteria
* allergic to fish, egg, soy and/or nut proteins
1 Hour
2 Months
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Dr. Soetomo General Hospital
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Meta Herdiana Hanindita, dr., Sp.A (K)
MD, Pediatrician (Consultant)
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Meta H Hanindita
Role: PRINCIPAL_INVESTIGATOR
Dr. Soetomo General Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Dr. Soetomo General Hospital
Surabaya, , Indonesia
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1983/105/II/2020
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.